Cartesian Therapeutics (RNAC) Price to Sales (2016 - 2026)
Cartesian Therapeutics' (RNAC) Price to Sales came in at 211.91 for Q2 2026, down 19.5% from 263.30 a year earlier but up 114.3% from the prior quarter.
Powered by 
Analysis
Cartesian Therapeutics (RNAC) Price to Sales (2016 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics' Price to Sales stood at 67.05, up 743.2% from FY2024.
- In prior years, Cartesian Therapeutics' Price to Sales was 7.95 in FY2024 (-93.8%), 128.71 in FY2023 (+174.8%), 46.83 in FY2022 (-67.0%) and 142.11 in FY2021 (-76.0%).
- Quarterly Price to Sales has run from a low of 4.15 in Q1 2024 to a high of 263.30 in Q2 2025 over five years.
- On a year-over-year basis, Price to Sales increased in three of the last six quarters, with growth averaging 260.9%.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q1 2026, with growth of 888.7%; the weakest was Q1 2024, with a decline of 94.6%.
- According to Business Quant data, Price to Sales for the three prior quarters was 98.90 (Q1 2026), 67.05 (Q4 2025) and 243.59 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Cartesian Therapeutics | 210.06 Mn | -304.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 414.74 |
| Jun 30, 2026 | 378.01 |
| Mar 31, 2026 | 91.05 |
| Sep 30, 2025 | 243.59 |
| Jun 30, 2025 | 263.30 |
| Mar 31, 2025 | 10.00 |
| Dec 31, 2024 | 7.95 |
| Sep 30, 2024 | 8.04 |
| Jun 30, 2024 | 8.89 |
| Mar 31, 2024 | 4.15 |
| Dec 31, 2023 | 128.71 |
| Sep 30, 2023 | 142.60 |
| Jun 30, 2023 | 105.87 |
| Mar 31, 2023 | 77.35 |
| Dec 31, 2022 | 46.83 |
| Sep 30, 2022 | 60.76 |
| Jun 30, 2022 | 47.02 |
| Mar 31, 2022 | 42.49 |
| Dec 31, 2021 | 142.11 |
| Sep 30, 2021 | 214.74 |
API Access
Cartesian Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=RNAC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();